Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 11 Prostatic Neoplasms 7 Fallopian Tube Neoplasms 4 Neoplasms 3 Neoplasm Metastasis 3 Breast Neoplasms 3 Prostatic Neoplasms, Castration-Resistant 2 Carcinoma, Ovarian Epithelial 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 SCLC,Extensive Stage 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Ovarian Carcinosarcoma 1 Oropharyngeal Neoplasms 1 Mouth Neoplasms 1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1 Metastatic Castration-sensitive Prostate Cancer 1 Lung Neoplasms 1 Laryngeal Diseases 1 Hereditary Sensory and Autonomic Neuropathies 1 Hemangiosarcoma 1 Head and Neck Neoplasms 1 Glioblastoma 1 Endometrial Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Neuroendocrine 1

Interventions

niraparib 1 atezolizumab 1 Etoposide 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

SCLC,Extensive Stage × niraparib × 90 days × Clear all

NCT05718323 2026-05-29

RAISE

ETOP IBCSG Partners Foundation

Phase 2 Recruiting

SCLC,Extensive Stage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡